The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Carfilzomib weekly 20/56mg/m², lenalidomide and dexamethasone for early relapsed refractory multiple myeloma.
 
Valentine Richez
No Relationships to Disclose
 
Stephanie Guidez
No Relationships to Disclose
 
Isabelle Azais
No Relationships to Disclose
 
Geraldine Durand
No Relationships to Disclose
 
Vincent Javaugue
No Relationships to Disclose
 
Antoine Brigaud
No Relationships to Disclose
 
Antoine Machet
No Relationships to Disclose
 
Niels Moya
No Relationships to Disclose
 
Cecile Gruchet
No Relationships to Disclose
 
Arthur Bobin
No Relationships to Disclose
 
Anthony Levy
No Relationships to Disclose
 
Florence Sabirou
No Relationships to Disclose
 
Celine Dieval
No Relationships to Disclose
 
Emmanuel Fleck
No Relationships to Disclose
 
Isabelle Princet
No Relationships to Disclose
 
Delphine Bauwens
No Relationships to Disclose
 
Guillemette Fouquet
No Relationships to Disclose
 
Frank Bridoux
No Relationships to Disclose
 
Herve Avet-Loiseau
No Relationships to Disclose
 
Xavier Leleu
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Merck; Mundipharma; Novartis; Pierre Fabre; Roche; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen-Cilag; Karyopharm Therapeutics; Merck; Mundipharma; Novartis; Roche; Takeda
Travel, Accommodations, Expenses - Takeda